Blood collection to assist in development of a biomarker that predicts the severity and prognosis of myathenia gravis
The purpose of this study is to investigate whether the bacterial population of the GI tract may be a contributing factor to the onset of immune-mediated hemolytic anemia or thrombocytopenia in dogs.
Evaluating safety and anti-cancer activity of oral PAC-1 used with hydroxyurea for canine meningioma
The goal of this study is to determine whether slowing down the heart rate in canine atrial fibrillation improves survival.
Seeking dogs with specific tumors to help us further cancer research.
Further evaluation of the Listeria vaccine in dogs with osteosarcoma.
A study evaluating whether a new prescription diet will slow the progression of mitral valve disease in dogs.
Assessing the Big Barker therapeutic mattress in dogs with osteoarthritis
A study of the cutaneous and rectal microbiome and the effect of cyclosporine therapy.
A modified Listeria vaccine for female dogs with bladder cancer.
Assessing novel therapeutic that will be evaluated for its effect on the development and progression of osteoarthritis in dogs following CCL rupture and TPLO surgery
We are testing a heparin derivative that is anti-inflammatory without being anticoagulant.
Penn Vet is conducting a study to determine if near-infrared imaging can improve the surgeon’s ability to see cancer and cancer margins during surgery to remove feline soft tissue sarcomas.
Clinical trial evaluating surgery in combination with immunotherapy for cats with fibrosarcoma
Immune cells (known as T cells) are taken from the peripheral blood, stimulated, expanded and genetically modified in the laboratory to express a surface receptor that recognizes B cells
A clinical trial evaluating the outcome of dogs with patellofemoral osteoarthritis due to the rupture of the Cranial Cruciate Ligament in one stifle, then stabilized with the Tibial Plateau Leveling Osteotomy (TPLO) procedure
We propose to evaluate markers of inflammation, hemolysis, and endothelial activation in a randomized clinical trial in which dogs with primary immune-mediated hemolytic anemia and immune-mediated thrombocytopenia would receive fresh or old RBCs.